BioLineRx (BLRX) Tops Q3 EPS by 15c
Tweet
Share
E-mailGet Alerts BLRX Hot Sheet
Join SI Premium – FREE
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.01), $0.15 better than the analyst estimate of ($0.16).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- BAE Systems Plc (BA:LN) (BAESY) New Top Pick in EU Defence at Morgan Stanley
- H.B. Fuller makes £715M cash offer to acquire Advanced Medical Solutions
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
